Exact Sciences Total Assets 2006-2020 | EXAS

Exact Sciences total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Exact Sciences total assets for the quarter ending September 30, 2020 were $4.354B, a 147.51% increase year-over-year.
  • Exact Sciences total assets for 2019 were $3.506B, a 130.03% increase from 2018.
  • Exact Sciences total assets for 2018 were $1.524B, a 154.61% increase from 2017.
  • Exact Sciences total assets for 2017 were $0.599B, a 58.75% increase from 2016.
Exact Sciences Annual Total Assets
(Millions of US $)
2019 $3,506
2018 $1,524
2017 $599
2016 $377
2015 $364
2014 $313
2013 $147
2012 $112
2011 $97
2010 $97
2009 $26
2008 $6
2007 $15
2006 $24
2005 $38
Exact Sciences Quarterly Total Assets
(Millions of US $)
2020-09-30 $4,354
2020-06-30 $4,468
2020-03-31 $4,461
2019-12-31 $3,506
2019-09-30 $1,759
2019-06-30 $1,782
2019-03-31 $1,771
2018-12-31 $1,524
2018-09-30 $1,510
2018-06-30 $1,483
2018-03-31 $1,257
2017-12-31 $599
2017-09-30 $587
2017-06-30 $583
2017-03-31 $350
2016-12-31 $377
2016-09-30 $403
2016-06-30 $289
2016-03-31 $324
2015-12-31 $364
2015-09-30 $394
2015-06-30 $253
2015-03-31 $279
2014-12-31 $313
2014-09-30 $235
2014-06-30 $256
2014-03-31 $134
2013-12-31 $147
2013-09-30 $155
2013-06-30 $163
2013-03-31 $100
2012-12-31 $112
2012-09-30 $123
2012-06-30 $76
2012-03-31 $88
2011-12-31 $97
2011-09-30 $78
2011-06-30 $85
2011-03-31 $91
2010-12-31 $97
2010-09-30 $36
2010-06-30 $39
2010-03-31 $24
2009-12-31 $26
2009-09-30 $28
2009-06-30 $29
2009-03-31 $22
2008-12-31 $6
2008-09-30 $7
2008-06-30 $10
2008-03-31 $12
2007-12-31 $15
2007-09-30 $17
2007-06-30 $19
2007-03-31 $21
2006-12-31 $24
2006-09-30 $27
2006-06-30 $30
2006-03-31 $33
2005-12-31 $38
2005-09-30 $41
2005-06-30 $46
2005-03-31 $50
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $23.155B $0.876B
EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than twenty years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies would help to enable detection of colorectal cancer so that more people can be effectively treated.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $149.676B 15.65
Bristol Myers Squibb (BMY) United States $146.690B 10.46
CSL (CSLLY) Australia $97.146B 0.00
Gilead Sciences (GILD) United States $85.440B 11.36
Vertex Pharmaceuticals (VRTX) United States $62.750B 29.18
Illumina (ILMN) United States $61.466B 84.54
Regeneron Pharmaceuticals (REGN) United States $58.496B 20.75
Moderna (MRNA) United States $58.169B 0.00
Biogen (BIIB) United States $42.401B 7.53
Alexion Pharmaceuticals (ALXN) United States $35.304B 14.06
BeiGene (BGNE) Cayman Islands $34.370B 0.00
Seagen (SGEN) United States $32.583B 85.77
Genmab (GMAB) Denmark $27.988B 33.10
Genmab (GNMSF) Denmark $26.645B 6.14
BioNTech SE (BNTX) Germany $25.027B 0.00
Incyte (INCY) United States $22.009B 0.00
Alnylam Pharmaceuticals (ALNY) United States $20.412B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.788B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.603B 66.75
Horizon Therapeutics Public (HZNP) Ireland $17.328B 24.77
BioMarin Pharmaceutical (BMRN) United States $16.151B 107.19
Guardant Health (GH) United States $15.726B 0.00
ARGENX SE-ADR (ARGX) Netherlands $14.928B 0.00
Bio-Techne Corp (TECH) United States $13.607B 87.02
CRISPR Therapeutics AG (CRSP) Switzerland $12.906B 0.00
QIAGEN (QGEN) Netherlands $12.264B 27.61
Repligen (RGEN) United States $11.328B 160.66
Mirati Therapeutics (MRTX) United States $10.710B 0.00
Denali Therapeutics (DNLI) United States $9.777B 0.00
Twist Bioscience (TWST) United States $9.045B 0.00
Adaptive Biotechnologies (ADPT) United States $8.960B 0.00
Ultragenyx Pharmaceutical (RARE) United States $8.959B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.577B 0.00
Ascendis Pharma (ASND) Denmark $8.487B 0.00
Fate Therapeutics (FATE) United States $8.388B 0.00
Novavax (NVAX) United States $8.369B 0.00
Acceleron Pharma (XLRN) United States $7.585B 0.00
Sarepta Therapeutics (SRPT) United States $7.584B 0.00
Galapagos (GLPG) Belgium $7.282B 0.00
Exelixis (EXEL) United States $7.080B 47.54
Halozyme Therapeutics (HALO) United States $6.597B 305.00
NeoGenomics (NEO) United States $6.319B 1897.00
Beam Therapeutics (BEAM) United States $5.942B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.829B 17.04
Blueprint Medicines (BPMC) United States $5.735B 18.99
Vir Biotechnology (VIR) United States $5.655B 0.00
Emergent Biosolutions (EBS) United States $5.638B 18.50
Certara (CERT) United States $5.630B 0.00
Amicus Therapeutics (FOLD) United States $5.326B 0.00
Eidos Therapeutics (EIDX) United States $4.751B 0.00
China Biologic Products (CBPO) China $4.660B 30.20
Arena Pharmaceuticals (ARNA) United States $4.537B 0.00
Insmed (INSM) United States $4.468B 0.00
Intellia Therapeutics (NTLA) United States $4.218B 0.00
Editas Medicine (EDIT) United States $4.104B 0.00
Reata Pharmaceuticals (RETA) United States $3.997B 0.00
Arvinas (ARVN) United States $3.995B 0.00
MorphoSys AG (MOR) Germany $3.919B 141.86
Legend Biotech (LEGN) United States $3.676B 0.00
Alkermes (ALKS) Ireland $3.640B 35.73
Bluebird Bio (BLUE) United States $3.193B 0.00
I-Mab (IMAB) China $3.022B 0.00
Global Blood Therapeutics (GBT) United States $2.987B 0.00
Amarin (AMRN) Ireland $2.956B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.737B 0.00
Intra-Cellular Therapies (ITCI) United States $2.719B 0.00
Ligand Pharmaceuticals (LGND) United States $2.509B 65.00
Arcus Biosciences (RCUS) United States $2.479B 0.00
Sorrento Therapeutics (SRNE) United States $2.440B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.346B 0.00
Seres Therapeutics (MCRB) United States $2.267B 0.00
Zymeworks (ZYME) Canada $2.217B 0.00
Sangamo Therapeutics (SGMO) United States $2.129B 0.00
NantKwest (NK) United States $2.064B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.057B 17.02
Scholar Rock Holding (SRRK) United States $2.041B 0.00
Viela Bio (VIE) United States $2.011B 0.00
Myriad Genetics (MYGN) United States $1.997B 0.00
Vericel (VCEL) United States $1.982B 0.00
PHARMA MAR SA (PHMMF) Spain $1.982B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.936B 0.00
NGM Biopharmaceuticals (NGM) United States $1.928B 0.00
Bionano Genomics (BNGO) United States $1.927B 0.00
Genetron Holdings (GTH) China $1.891B 0.00
Revance Therapeutics (RVNC) United States $1.880B 0.00
Inovio Pharmaceuticals (INO) United States $1.816B 0.00
UniQure (QURE) Netherlands $1.769B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.701B 0.00
REGENXBIO (RGNX) United States $1.683B 0.00
Precigen (PGEN) United States $1.651B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.643B 0.00
Heska (HSKA) United States $1.580B 0.00
Castle Biosciences (CSTL) United States $1.528B 0.00
Codexis (CDXS) United States $1.487B 0.00
Cytokineticsorporated (CYTK) United States $1.475B 0.00
Zealand Pharma (ZEAL) Denmark $1.458B 0.00
Alector (ALEC) United States $1.438B 0.00
Coherus BioSciences (CHRS) United States $1.409B 9.31
Travere Therapeutics (TVTX) United States $1.387B 0.00
Mersana Therapeutics (MRSN) United States $1.372B 0.00
Zealand Pharma (ZLDPF) Denmark $1.343B 0.00
Adverum Biotechnologies (ADVM) United States $1.342B 0.00
Cellectis S.A (CLLS) France $1.330B 0.00
Frequency Therapeutics (FREQ) United States $1.276B 0.00
Athenex (ATNX) United States $1.250B 0.00
Epizyme (EPZM) United States $1.221B 0.00
Antibe Therapeutics (ATBPF) Canada $1.193B 0.00
Northwest Biotherapeutics (NWBO) United States $1.146B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.093B 0.00
Mesoblast (MESO) Australia $1.079B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.026B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.022B 0.00
Sutro Biopharma (STRO) United States $1.006B 0.00
Morphic Holding (MORF) United States $0.982B 0.00
Cara Therapeutics (CARA) United States $0.979B 0.00
Pliant Therapeutics (PLRX) United States $0.967B 0.00
MiMedx (MDXG) United States $0.952B 0.00
Protagonist Therapeutics (PTGX) United States $0.904B 0.00
Gritstone Oncology (GRTS) United States $0.901B 0.00
Merus (MRUS) Netherlands $0.890B 0.00
Kadmon Holdings (KDMN) United States $0.885B 0.00
Pharming Group (PHGUF) Netherlands $0.879B 23.42
Syndax Pharmaceuticals (SNDX) United States $0.874B 0.00
MannKind (MNKD) United States $0.872B 0.00
Compugen (CGEN) Israel $0.866B 0.00
Avid Bioservices (CDMO) United States $0.834B 0.00
VBI Vaccines (VBIV) United States $0.784B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.780B 39.63
ZIOPHARM Oncology Inc (ZIOP) United States $0.780B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.748B 0.00
Celldex Therapeutics (CLDX) United States $0.745B 0.00
Agenus (AGEN) United States $0.742B 0.00
Dynavax Technologies (DVAX) United States $0.722B 0.00
Clovis Oncology (CLVS) United States $0.698B 0.00
Precision BioSciences (DTIL) United States $0.697B 0.00
ALBIREO PHARMA (ALBO) United States $0.694B 0.00
Syros Pharmaceuticals (SYRS) United States $0.687B 0.00
AnaptysBio (ANAB) United States $0.681B 0.00
AquaBounty Technologies (AQB) United States $0.677B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.639B 0.00
DBV Technologies S.A (DBVT) France $0.612B 0.00
Curis (CRIS) United States $0.604B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.601B 0.00
Five Prime Therapeutics (FPRX) United States $0.599B 0.00
Cel-Sci (CVM) United States $0.595B 0.00
MeiraGTx Holdings (MGTX) United States $0.582B 0.00
Affimed (AFMD) Germany $0.579B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.571B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.559B 0.00
Anika Therapeutics (ANIK) United States $0.550B 74.40
Prothena (PRTA) Ireland $0.550B 0.00
Geron (GERN) United States $0.546B 0.00
Pandion Therapeutics (PAND) United States $0.533B 0.00
Spero Therapeutics (SPRO) United States $0.515B 0.00
WAVE Life Sciences (WVE) Singapore $0.500B 0.00
Puma Biotechnology (PBYI) United States $0.499B 0.00
FORTE BIOSCIENC (FBRX) United States $0.493B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.477B 0.00
AC Immune SA (ACIU) Switzerland $0.468B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.467B 0.00
Amryt Pharma (AMYT) United Kingdom $0.466B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.465B 0.00
UROGEN PHARMA (URGN) United States $0.462B 0.00
Cue Biopharma (CUE) United States $0.453B 0.00
Starpharma Holdings (SPHRY) Australia $0.451B 0.00
Selecta Biosciences (SELB) United States $0.437B 0.00
XOMA (XOMA) United States $0.437B 0.00
Athersys (ATHX) United States $0.425B 0.00
BioDelivery Sciences (BDSI) United States $0.425B 20.00
Kala Pharmaceuticals (KALA) United States $0.398B 0.00
ANI Pharmaceuticals (ANIP) United States $0.397B 10.11
Lineage Cell Therapeutics (LCTX) United States $0.388B 0.00
NextCure (NXTC) United States $0.375B 0.00
Trevena (TRVN) United States $0.367B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.366B 0.00
Cardiff Oncology (CRDF) United States $0.366B 0.00
Verastem (VSTM) United States $0.363B 0.00
Cellular Biomedicine (CBMG) United States $0.353B 0.00
AMMO (POWW) United States $0.345B 0.00
Arbutus Biopharma (ABUS) United States $0.340B 0.00
Fortress Biotech (FBIO) United States $0.333B 0.00
Innate Pharma S.A (IPHA) France $0.330B 0.00
CytomX Therapeutics (CTMX) United States $0.328B 0.00
Voyager Therapeutics (VYGR) United States $0.326B 8.36
IBio (IBIO) United States $0.311B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.309B 0.00
Kamada (KMDA) Israel $0.303B 14.19
ChromaDex (CDXC) United States $0.302B 0.00
Bellus Health (BLU) Canada $0.292B 0.00
OSMOTICA PHARM (OSMT) United States $0.289B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
HOOKIPA Pharma (HOOK) United States $0.277B 0.00
CorMedix Inc (CRMD) United States $0.273B 0.00
Cerecor (CERC) United States $0.255B 0.00
Aptinyx (APTX) United States $0.247B 0.00
Palatin Technologies (PTN) United States $0.244B 0.00
VolitionRX (VNRX) United States $0.241B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.239B 0.00
ADMA Biologics Inc (ADMA) United States $0.234B 0.00
Checkpoint Therapeutics (CKPT) United States $0.233B 0.00
Abeona Therapeutics (ABEO) United States $0.230B 0.00
Eton Pharmaceuticals (ETON) United States $0.219B 0.00
Theratechnologies (THTX) Canada $0.215B 0.00
Cogent Biosciences (COGT) United States $0.213B 0.00
Idera Pharmaceuticals (IDRA) United States $0.211B 0.00
TELA Bio (TELA) United States $0.204B 0.00
Exicure (XCUR) United States $0.201B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.199B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Strongbridge Biopharma (SBBP) United States $0.196B 0.00
GENFIT S.A (GNFT) France $0.196B 0.00
Biofrontera AG (BFRA) Germany $0.192B 0.00
Kindred Biosciences (KIN) United States $0.192B 0.00
Pluristem Therapeutics (PSTI) Israel $0.191B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.186B 0.00
Nicox SA (NICXF) France $0.182B 0.00
Clearside Biomedical (CLSD) United States $0.179B 0.00
DiaMedica Therapeutics (DMAC) United States $0.174B 0.00
Oncobiologics (OTLK) United States $0.173B 0.00
Evogene (EVGN) Israel $0.170B 0.00
Orgenesis (ORGS) United States $0.162B 336.00
Lumos Pharma (LUMO) United States $0.160B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.158B 0.00
VTv Therapeutics (VTVT) United States $0.157B 0.00
Dyadic (DYAI) United States $0.157B 0.00
Aptevo Therapeutics (APVO) United States $0.152B 0.00
Prometic Life Sciences (LMNL) Canada $0.151B 0.00
Catalyst Biosciences (CBIO) United States $0.151B 0.00
Protalix BioTherapeutics (PLX) Israel $0.149B 0.00
Enzo Biochem (ENZ) United States $0.148B 0.00
TRACON Pharmaceuticals (TCON) United States $0.146B 0.00
Synlogic (SYBX) United States $0.142B 0.00
Seelos Therapeutics (SEEL) United States $0.142B 0.00
Vascular Biogenics (VBLT) Israel $0.139B 0.00
Cocrystal Pharma (COCP) United States $0.139B 0.00
Liquidia Technologies (LQDA) United States $0.129B 0.00
PHASEBIO PHARMA (PHAS) United States $0.127B 0.00
Applied Genetic Technologies (AGTC) United States $0.126B 0.00
Prima BioMed (IMMP) Australia $0.125B 0.00
Ecology Coatings (ABVC) United States $0.123B 0.00
AIT Therapeutics (XAIR) United States $0.122B 0.00
Cidara Therapeutics (CDTX) United States $0.113B 0.00
Celyad SA (CYAD) Belgium $0.113B 0.00
Cyclerion Therapeutics (CYCN) United States $0.113B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.110B 0.00
Aytu Bioscience (AYTU) United States $0.109B 0.00
Organovo Holdings (ONVO) United States $0.103B 0.00
ARAVIVE, INC (ARAV) United States $0.096B 0.00
Novogen (KZIA) Australia $0.095B 0.00
Stealth BioTherapeutics (MITO) United States $0.094B 44.75
Windtree Therapeutics (WINT) United States $0.094B 0.00
Adocia (ADOCY) France $0.091B 0.00
CollPlant Holdings (CLGN) Israel $0.084B 0.00
CytRx (CYTR) United States $0.080B 0.00
Genetic Technologies (GENE) Australia $0.076B 0.00
Purple Biotech (PPBT) Israel $0.071B 0.00
ARIDIS PHARMACT (ARDS) United States $0.071B 0.00
AnPac Bio-Medical Science (ANPC) China $0.066B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.066B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.061B 0.00
Acorda Therapeutics (ACOR) United States $0.059B 0.00
Emmaus Life Sciences (EMMA) United States $0.059B 0.00
Soligenix (SNGX) United States $0.058B 0.00
Edesa Biotech (EDSA) Canada $0.058B 0.00
Cleveland BioLabs (CBLI) United States $0.058B 0.00
Pulmatrix (PULM) United States $0.056B 0.00
Happiness Biotech Group (HAPP) China $0.056B 0.00
Enveric Biosciences (ENVB) United States $0.056B 0.00
Appili Therapeutics (APLIF) Canada $0.054B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.054B 0.00
BioCardia (BCDA) United States $0.053B 0.00
Yumanity Therapeutics (YMTX) United States $0.053B 0.00
Celsion (CLSN) United States $0.052B 0.00
Advaxis (ADXS) United States $0.050B 0.00
Chanticleer Holdings (SONN) United States $0.049B 0.00
IMMURON (IMRN) Australia $0.044B 0.00
Spherix (AIKI) United States $0.043B 0.00
Prana Biotechnology (ATHE) Australia $0.042B 0.00
ATyr Pharma (LIFE) United States $0.042B 0.00
AEterna Zentaris (AEZS) United States $0.042B 0.00
Alimera Sciences (ALIM) United States $0.040B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.036B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.029B 0.00
Neuralstem (SNCA) United States $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Lexaria Bioscience (LEXX) Canada $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.022B 0.00
GeoVax Labs (GOVX) United States $0.019B 0.00
Invo BioScience (INVO) United States $0.015B 0.00
BioPharmX (TMBR) United States $0.015B 0.00
CTD Holdings (CYTH) United States $0.011B 0.00
Benitec Biopharma (BNTC) United States $0.005B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00